These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6785370)

  • 1. Plasma "prorenin"-renin in Bartter's syndrome, cystic fibrosis, and chloride deficiency, and the effect of prostaglandin synthetase inhibition.
    Chan LL; Osmond DH; Balfe JW; Halperin ML
    J Lab Clin Med; 1981 Jun; 97(6):785-90. PubMed ID: 6785370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The kallikrein-kinin system in Bartter's syndrome and its response to prostaglandin synthetase inhibition.
    Vinci JM; Gill JR; Bowden RE; Pisano JJ; Izzo JL; Radfar N; Taylor AA; Zusman RM; Bartter FC; Keiser HR
    J Clin Invest; 1978 Jun; 61(6):1671-82. PubMed ID: 96139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial natriuretic peptide levels during angiotensin infusion and indomethacin administration are consistent with angiotensin-mediated regulation in man.
    Klemm SA; Tunny TJ; Gordon RD
    J Hypertens Suppl; 1987 Dec; 5(5):S75-8. PubMed ID: 2965235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactive renin and aldosterone in Bartter's syndrome.
    McKenzie IM; Heiman D; Winter JS; McKenzie JK
    Clin Invest Med; 1987 Jul; 10(4):303-8. PubMed ID: 3308240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of prostaglandin synthetase inhibition on captopril-induced changes in renal function in Bartter's syndrome.
    Rudin A; Granérus G; Aurell M
    Scand J Urol Nephrol Suppl; 1984; 79():59-62. PubMed ID: 6433438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated levels of plasma atrial natriuretic peptide in Bartter's syndrome fall to normal with indomethacin: implications for atrial natriuretic peptide regulation in man.
    Gordon RD; Tunny TJ; Klemm SA; Hamlet SM
    J Hypertens Suppl; 1986 Dec; 4(6):S555-8. PubMed ID: 2956391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High level of plasma inactive renin in Bartter's syndrome.
    Nagai H; Matsunaga M; Ogawa K; Kuwahara T; Kanatsu K; Pak CH; Hara A; Tamura T; Kono T; Kawai C
    Jpn Circ J; 1984 Jul; 48(7):633-7. PubMed ID: 6381782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Sar1-ala8-angiotensin II on blood pressure and renin in Bartter's syndrome, before and after treatment with prostaglandin synthetase inhibitors.
    Rudin A; Aurell M; Hansson L; Westberg G
    Scand J Clin Lab Invest; 1979 Oct; 39(6):543-50. PubMed ID: 119300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bartter's syndrome. Differentiation into two clinical groups.
    Robson WL; Arbus GS; Balfe JW
    Am J Dis Child; 1979 Jun; 133(6):636-8. PubMed ID: 35973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical findings, pathogenesis and treatment of Bartter's syndrome (author's transl)].
    Ploier R; Tulzer W
    Wien Med Wochenschr; 1981; 131(11):287-93. PubMed ID: 7020264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of prostaglandins in Bartter's syndrome.
    Winterborn MH; Hewitt GJ; Mitchell MD
    Int J Pediatr Nephrol; 1984 Mar; 5(1):31-8. PubMed ID: 6370882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of treatment with prostaglandin synthetase inhibitors on the erythrocyte sodium transport abnormality of Bartter's syndrome.
    Cole CH; O'Regan S
    Pediatr Res; 1981 Jun; 15(6):926-9. PubMed ID: 6787547
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term use of propranolol, ibuprofen, and spironolactone in the management of Bartter's syndrome.
    Cunningham RJ; Brouhard BH; Berger M; Petrusick T; Travis LB
    Pediatrics; 1979 May; 63(5):754-6. PubMed ID: 440896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of prostaglandins in the pathogenesis of Bartter's syndrome.
    Fichman MP; Telfer N; Zia P; Speckart P; Golub M; Rude R
    Am J Med; 1976 May; 60(6):785-97. PubMed ID: 798488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin synthetase inhibitors in Bartter's syndrome. Effect on immunoreactive prostaglandin E excretion.
    Bowden RE; Gill JR; Radfar N; Taylor AA; Keiser HR
    JAMA; 1978 Jan; 239(2):117-21. PubMed ID: 412983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bartter's syndrome: the long term effects of indomethacin on growth (author's transl)].
    Floret D; David M; Roux A; Hage GN; Teyssier G
    Nouv Presse Med; 1979 Jan; 8(1):17-21. PubMed ID: 122007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation between renin and prorenin in plasma from hypertensive patients and normal people: evidence for different renin:prorenin ratios.
    Leckie BJ; Morton JJ
    J Hum Hypertens; 1995 Jun; 9(6):493-6. PubMed ID: 7473533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Bartter's syndrome in early childhood with prostaglandin synthetase inhibitors.
    Littlewood JM; Lee MR; Meadow SR
    Arch Dis Child; 1978 Jan; 53(1):43-8. PubMed ID: 415668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoreactive renin, prorenin, and enzymatically active renin in plasma during pregnancy and in women taking oral contraceptives.
    Derkx FH; Steunkel C; Schalekamp MP; Visser W; Huisveld IH; Schalekamp MA
    J Clin Endocrinol Metab; 1986 Oct; 63(4):1008-15. PubMed ID: 3528208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A hitherto unreported case of 21-hydroxylase deficiency associated with Bartter's syndrome and a balanced 6-9 translocation.
    Yabe R; Mizuno K; Ojima M; Ogawa S; Tani M; Niimura S; Watari H; Kunii N; Suenaga K; Yatabe Y
    J Med; 1987; 18(5-6):333-49. PubMed ID: 3333163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.